- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
High-Risk Centers and the Benefits for Lower-Risk TransplantsThere does not appear to be any comparative advantage for low-risk hematopoietic cell transplantation patients to seek care from high-risk centers.
Latest:
Cost Per Response Analysis of Strategies for Chronic Immune ThrombocytopeniaThis decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.
Latest:
Post-treatment Surveillance in a Large Cohort of Patients With Colon CancerAdherence to colon cancer post-treatment surveillance was low, although proportions of patients complying with office visits and colonoscopy were reasonably high.
Latest:
Psychological Family Intervention for Poorly Controlled Type 2 DiabetesA family-based intervention targeting negative and/or inaccurate illness perceptions in patients with poorly controlled type 2 diabetes was effective in improving glycemic control.
Latest:
State-Level Projections of Cancer-Related Medical Care Costs: 2010 to 2020State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.
Latest:
Are Chronically Ill Patients High Users of Homecare Services in Canada?Assessments of self-care capacity and other measures were the most precise ways to identify individuals who could be classified as chronically ill, in their status as the highest users, both individually and collectively, of homecare services.
Latest:
Patient Satisfaction: Opportunity for Better Multiple Sclerosis TherapiesExperts in multiple sclerosis discuss overall patient satisfaction with current disease-modifying therapies for multiple sclerosis, highlighting the need for more therapies that stave off decline and disease progression.
Latest:
The Impact of HDHPs on Service Use and Spending for Substance Use DisordersOffering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.
Latest:
Solid-Organ Transplant Recipients With Hyperglycemia on Admission Face Worse OutcomesElevated glucose levels are common in solid-organ transplant recipients and associated with short- and long-term mortality risks in hospitalized transplant recipients. This increased mortality risk was independent of age, gender, smoking, alcohol, or comorbidities.
Latest:
Population Health in Primary Care: Cost, Quality, and Experience ImpactAn evaluation of the use of predictive modeling for primary care resource allocation demonstrated reduced spending and improved quality and patient experience for publicly insured adults.
Latest:
Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent ParticipantsOver 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Latest:
Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional MedicareAmong near-poor Black and Hispanic individuals, Medicare Advantage was associated with increased vision care and some, although not uniform, reductions in access disparities vs traditional Medicare.
Latest:
Impact of Care Coordination Based on Insurance and Zip CodeA care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.
Latest:
A Step in the Digital Direction: From Paper Logs to Electronic Data CaptureResearch documentation is a critical aspect of running a clinical trial. Key patient information such as informed consent, adverse events (AEs), concomitant medications, and medical and surgical histories are collected and used to determine patient safety and efficacy as the trial proceeds. Ultimately, the sponsor may make decisions—ranging from modifying the dose of the investigational drug to closing the study due to AEs—based on the data collected.
Latest:
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic PrescriptionsTen percent of patients abandon newly initiated oral oncolytics at the pharmacy. Patients facing higher cost sharing or increased concurrent prescription activity have a higher abandonment rate.
